Rectal cancer: Mucinous carcinoma on magnetic resonance imaging indicates poor response to neoadjuvant chemoradiation

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 2, 2012, Pages 842-848

  Oberholzer, Katja ^a   Menig, Matthias ^a   Kreft, Andreas ^a   Schneider, Astrid ^a   Junginger, Theodor ^a   Heintz, Achim ^b   Kreitner, Karl Friedrich ^a   Hötker, Andreas M ^a   Hansen, Torsten ^a   Düber, Christoph ^a   Schmidberger, Heinz ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b St Hildegardis Krankenhaus   (Germany)

Author keywords

Chemoradiation; Magnetic resonance imaging; Mucinous carcinoma; Pathologic response; Rectal cancer

Indexed keywords

5-FLUOROURACIL; CHEMORADIATION; DISEASE PROGRESSION; MINIMUM DISTANCE; MUCINOUS CARCINOMA; NEOADJUVANT CHEMORADIATION; PATHOLOGIC RESPONSE; PROSPECTIVE STUDY; RECTAL CANCER; SURGICAL SPECIMENS; TUMOR INVASION; TUMOR RESECTION; TUMOR STAGING; TUMOR VOLUMES;

DISEASES; RESONANCE; SURGERY; TUMORS;

MAGNETIC RESONANCE IMAGING;

FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CANCER SURGERY; CHEMORADIOTHERAPY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCINOUS CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM CARCINOMA; TREATMENT RESPONSE; TUMOR VOLUME;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA; CHEMORADIOTHERAPY; DOSE FRACTIONATION; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84855839649     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.08.057     Document Type: Article

References (53)

1. K.C. Peeters, C.A. Marijnen, and I.D. Nagtegaal The TME trial after a median follow-up of 6 years: Increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma Ann Surg 246 2007 693 701
2. V. Valentini, C. Aristei, and B. Glimelius Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2) Radiother Oncol 92 2009 148 163
3. A. Wibe, A. Syse, and E. Andersen Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: Anterior vs abdominoperineal resection Dis Colon Rectum 47 2004 48 58
4. J. Folkesson, H. Birgisson, L. Pahlman, B. Cedermark, B. Glimelius, and U. Gunnarsson Swedish Rectal Cancer Trial: Long lasting benefits from radiotherapy on survival and local recurrence rate J Clin Oncol 23 2005 5644 5650
5. J.F. Bosset, L. Collette, and G. Calais Chemotherapy with preoperative radiotherapy in rectal cancer N Engl J Med 355 2006 1114 1123
6. S. Burton, G. Brown, I.R. Daniels, A.R. Norman, B. Mason, and D. Cunningham MRI directed multidisciplinary team preoperative treatment strategy: The way to eliminate positive circumferential margins? Br J Cancer 94 2006 351 357
7. A. Cervantes, I. Chirivella, E. Rodriguez-Braun, S. Campos, S. Navarro, and E. Garcia Granero A multimodality approach to localized rectal cancer Ann Oncol 17 Suppl 10 2006 129 134
8. I.D. Nagtegaal, and P. Quirke What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol 26 2008 303 312
9. M.J. Gosens, R.A. Klaassen, and I. Tan-Go Circumferential margin involvement is the crucial prognostic factor after multimodality treatment in patients with locally advanced rectal carcinoma Clin Cancer Res 13 2007 6617 6623
10. S. Mawdsley, R. Glynne-Jones, and J. Grainger Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival? Int J Radiat Oncol Biol Phys 63 2005 745 752
11. H. Bouzourene, F.T. Bosman, M. Matter, and P. Coucke Predictive factors in locally advanced rectal cancer treated with preoperative hyperfractionated and accelerated radiotherapy Hum Pathol 34 2003 541 548
12. M.J. Lahaye, S.M. Engelen, and P.J. Nelemans Imaging for predicting the risk factors - the circumferential resection margin and nodal disease - of local recurrence in rectal cancer: A meta-analysis Semin Ultrasound CT MR 26 2005 259 268
13. P. Hermanek, Th Junginger, and S. Merkel High-resolution magnetic resonance imaging (MRI) in patients with rectal carcer: Effectiveness in selection for neoadjuvant treatment Recent Res Devel Cancer 8 2006 259 268
14. S.R. Hamilton, and L.A. Aalton World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System 2000 IARC Press Lyon, France 105-120
15. N. Sengul, S.D. Wexner, and S. Woodhouse Effects of radiotherapy on different histopathological types of rectal carcinoma Colorectal Dis 8 2006 283 288
16. F.V. Negri, A. Wotherspoon, D. Cunningham, A.R. Norman, G. Chong, and P.J. Ross Mucinous histology predicts for reduced fluorouracil responsiveness and survival in advanced colorectal cancer Ann Oncol 16 2005 1305 1310
17. V. Catalano, F. Loupakis, and F. Graziano Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy Br J Cancer 100 2009 881 887
18. F. Grillo-Ruggieri, G. Mantello, and R. Berardi Mucinous rectal adenocarcinoma can be associated to tumor downstaging after preoperative chemoradiotherapy Dis Colon Rectum 50 2007 1594 1603
19. M.J. Kim, J.S. Park, and S.I. Park Accuracy in differentiation of mucinous and nonmucinous rectal carcinoma on MR imaging J Comput Assist Tomogr 27 2003 48 55
20. J.P. Arnoletti, and K.I. Bland Neoadjuvant and adjuvant therapy for rectal cancer Surg Oncol Clin N Am 15 2006 147 157
21. W. Schmiegel, A. Reinacher-Schick, and D. Arnold [Update S3-guideline "colorectal cancer" 2008] Z Gastroenterol 46 2008 799 840
22. P. Hermanek, Th Junginger, and S. Merkel High-resolution magnetic resonance imaging (MRI) in patients with rectal carcer: Effectiveness in selection for neoadjuvant treatment Recent Res Devel Cancer 8 2006 259 268
23. T. Junginger, P. Hermanek, K. Oberholzer, and H. Schmidberger [Rectal carcinoma: Is too much neoadjuvant therapy performed? Proposals for a more selective MRI based indication] Zentralbl Chir 131 2006 275 284
24. P. Quirke, P. Durdey, M.F. Dixon, and N.S. Williams Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision Lancet 2 1986 996 999
25. R. Glynne-Jones, S. Mawdsley, and J.R. Novell The clinical significance of the circumferential resection margin following preoperative pelvic chemo-radiotherapy in rectal cancer: Why we need a common language Colorectal Dis 8 2006 800 807
26. G. Brown, C.J. Richards, and R.G. Newcombe Rectal carcinoma: Thin-section MR imaging for staging in 28 patients Radiology 211 1999 215 222
27. G. Brown, C.J. Richards, and M.W. Bourne Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison Radiology 227 2003 371 377
28. B. Moran, G. Brown, and D. Cunningham Clarifying the TNM staging of rectal cancer in the context of modern imaging and neo-adjuvant treatment: 'y'u' and 'p' need 'mr' and 'ct' Colorectal Dis 10 2008 242 243
29. R. Sauer, H. Becker, and W. Hohenberger Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 2004 1731 1740
30. C. Wittekind, C. Compton, and P. Quirke A uniform residual tumor (R) classification: Integration of the R classification and the circumferential margin status Cancer 115 2009 34 83
31. L.H. Sobin, and C. Wittekind TNM classification of malignant tumors 6th ed 2002 Wiley New York, NY
32. O. Dworak, L. Keilhoz, and A. Hoffmann Pathological features of rectal cancer after preoperative Radiochemotherapy Int J Colorectal Dis 12 1997 19 23
33. I. Nagtegaal, C. Gaspar, C. Marijnen, C. Van De Velde, R. Fodde, and H. Van Krieken Morphological changes in tumour type after radiotherapy are accompanied by changes in gene expression profile but not in clinical behaviour J Pathol 204 2004 183 192
34. A. Suppiah, I.A. Hunter, and J. Cowley Magnetic resonance imaging accuracy in assessing tumour down-staging following chemoradiation in rectal cancer Colorectal Dis 11 2009 249 253
35. T. Kulkarni, S. Gollins, A. Maw, P. Hobson, R. Byrne, and D. Widdowson Magnetic resonance imaging in rectal cancer downstaged using neoadjuvant chemoradiation: Accuracy of prediction of tumour stage and circumferential resection margin status Colorectal Dis 10 2008 479 489
36. M.R. Torkzad, J. Lindholm, A. Martling, B. Cedermark, B. Glimelius, and L. Blomqvist MRI after preoperative radiotherapy for rectal cancer: Correlation with histopathology and the role of volumetry Eur Radiol 17 2007 1566 1573
37. R.F. Vliegen, G.L. Beets, and G. Lammering Mesorectal fascia invasion after neoadjuvant chemotherapy and radiation therapy for locally advanced rectal cancer: Accuracy of MR imaging for prediction Radiology 246 2008 454 462
38. K.T. Hoffmann, B. Rau, and P. Wust Restaging of locally advanced carcinoma of the rectum with MR imaging after preoperative radio-chemotherapy plus regional hyperthermia Strahlenther Onkol 178 2002 386 392
39. MERCURY Study group Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: Prospective observational study BMJ 333 2006 779 782
40. H. Zhang, S. Evertsson, and X. Sun Clinicopathological and genetic characteristics of mucinous carcinomas in the colorectum Int J Oncol 14 1999 1057 1061
41. C. Hanski Is mucinous carcinoma of the colorectum a distinct genetic entity? Br J Cancer 72 1995 1350 1356
42. B. Endrich, and P. Vaupel The role of microcirculation in the treatment of malignant tumours: Facts and fiction M. Molls, P. Vaupel, Blood perfusion and microenvironment of human tumors 1998 Springer-Verlag Berlin, Germany 19-39
43. Improved survival with preoperative radiotherapy in resectable rectal cancer Swedish Rectal Cancer Trial N Engl J Med 336 1997 980 987
44. K. Bujko, M.P. Nowacki, and A. Nasierowska-Guttmejer Sphincter preservation following preoperative radiotherapy for rectal cancer: Report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy Radiother Oncol 72 2004 15 24
45. C. Radu, A. Berglund, L. Pahlman, and B. Glimelius Short-course preoperative radiotherapy with delayed surgery in rectal cancer - a retrospective study Radiother Oncol 87 2008 343 349
46. I. Chau, G. Brown, and D. Cunningham Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer J Clin Oncol 24 2006 668 674
47. R. Glynne-Jones, S. Falk, T.S. Maughan, H.M. Meadows, and D. Sebag-Montefiore A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: A Colorectal Clinical Oncology Group Study Br J Cancer 96 2007 551 558
48. M. Mohiuddin, K. Winter, and E. Mitchell Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012 J Clin Oncol 24 2006 650 655
49. J. Shia, J.G. Guillem, H.G. Moore, S.K. Tickoo, J. Qin, L. Ruo, A. Suriawinata, P.B. Paty, B.D. Minsky, M.R. Weiser, L.K. Temple, W.D. Wong, and D.S. Klimstra Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome Am J Surg Pathol 28 2004 215 223
50. V. Valentini, C. Coco, A. Picciocchi, A.G. Morganti, L. Trodella, A. Ciabattoni, F. Cellini, B. Barbaro, S. Cogliandolo, G. Nuzzo, G.B. Doglietto, F. Ambesi-Impiombato, and M. Cosimelli Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients Int J Radiat Oncol Biol Phys 53 2002 664 674
51. E. Leteurtre, V. Gouyer, and K. Rousseau Differential mucin expression in colon carcinoma HT-29 clones with variable resistance to 5-fluorouracil and methotrexate Biol Cell 96 2004 145 151
52. C.W. Fan, H.A. Fan, and S.H. Hsu An in vitro short time-high dose drug exposure assay for predicting 5FU-resistance of colorectal cancer Cancer Lett 214 2004 181 188
53. M. Younes, P.R. Katikaneni, and J. Lechago The value of the preoperative mucosal biopsy in the diagnosis of colorectal mucinous adenocarcinoma Cancer 72 1993 3588 3592